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Abstract
Background: Sri Lanka has a high suicide rate, with more than 40 % of poisoning admissions due to overdose of
drugs with Paracetamol being the commonest. Data regarding cardiotoxicity to paracetamol is very minimal though
hepatotoxicity following poisoning is well studied. Paracetamol cardiotoxicity has rarely been clinically significant and may
have well been overlooked. The possibility that paracetamol overdose might be directly cardiotoxic has been the subject
of a few reports. Unexplained deaths and electrocardiographic changes associated with paracetamol poisoning have
also been reported in which cardiac origin cannot be clearly ruled out. Although some studies state that paracetamol
poisoning has no direct cardiotoxic effect, electrocardiographic changes due to metabolic derangement of hepatotoxicity
have been shown in certain studies. Thus, we conducted this study to assess in detail the cardiotoxic effect of
paracetamol poisoning.
Methods: This is a cross sectional descriptive study done on those with confirmed paracetamol poisoning. Serum
paracetamol levels, Electrocardiogram, Echocardiogram, troponin I, and other basic investigations were done.
Results: Paracetamol ingestion is more common among teenagers and the young population in Sri Lanka. Although
several cases of paracetamol poisoning induced cardiotoxicity has been described in the past, this study demonstrated
no electrocardiographic, echocardiographic or cardiac biomarkers changes of myocardial toxicity.
Conclusion: Though literature review support cardiotoxicity following paracetamol poisoning, our study does not
provide enough evidence for this. Continuous cardiac monitoring, serial troponin and echocaediogram assessment would
be voluble adjunct in its management. Further experiments and research in this subject would be useful with a larger
number of samples to further evaluate this important problem.
Background
Sri Lanka has a very high suicide rate, mainly due to
acute poisoning with pesticides. Since 1995 the suicide
rate in Sri Lanka has declined to 23 per 100,000 popula-
tion in 2006, and is attributed to a drop in case fatality
due to the reduction in toxicity of accessible pesticides,
and the implication of regulations to restrict the accessi-
bility of toxic pesticides [1]. Ingestion of pesticides as a
method of self-harm has become less frequent in recent
years in Sri Lanka. In urban districts in Sri Lanka, more
than 40 % of poisoning admissions were due to the over-
dose of drugs, medicaments and biological substances
but this trend is not restricted to urban areas alone.
However, though there is a shift of substances used in
self-poisoning from pesticides to medicinal drugs, there
is a steep rise in rates of self-poisoning in most districts,
which is a serious issue [2]. Over the past few years
paracetamol poisoning has shown a marked increase. It
is the most widely used over-the -counter analgesic/anti-
pyretic. The main reason for paracetamol to be the com-
monest drug responsible for self-poisoning is that it is
readily available [3–6]. It was the commonest drug
responsible for deliberate self-harm in the National
Hospital Sri Lanka in 2003 [4, 5]. It was also the com-
monest drug responsible for self-poisoning in the United
Kingdom, with 25 000 admissions from paracetamol be-
ing recorded in 2001 alone [7].
Paracetamol is predominantly metabolised to glucuro-
nide and sulphate conjugates, which are excreted in the
urine. Hepatotoxicity is related to the conversion of a
small proportion of the ingested dose to N-acetyl-p-benzo-
quinoneimine. In therapeutic doses, N-acetyl-p-benzoqui-
noneimine is detoxified by conjugation with glutathione in
the liver, but hepatic and renal damage may ensue once
the protective intracellular glutathione stores are depleted.
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N-acetylcysteine and methionine replenish glutathione
stores in the liver and kidney. Methionine is given orally
whereas N-acetylcysteine is available in oral and intraven-
ous form. There is also some evidence that N- acetylcys-
teine reduces mortality in paracetamol induced liver
failure, although the drug acts via a different mechanism
from glutathione repletion [8–13].
Though hepatotoxicity following paracetamol poison-
ing is well studied data regarding cardiotoxicity is very
minimal. While general experience suggests that para-
cetamol induced cardiotoxicity has rarely been clinically
significant, it may have been overlooked. The possibility
that an overdose of paracetamol might be directly cardi-
otoxic has been the subject of a few reports [14–19].
(Table 1) However the true incidence is unknown as ser-
ial electrocardiograph (ECG) monitoring is not part of
routine clinical management. Moreover, anxieties have
been expressed regarding unexplained deaths associated
with paracetamol poisoning, with some occurring within
24 h of ingestion [13]. It cannot be ruled out that a
number of these may have been cardiac in origin [9].
Dysrhythmias and other ECG abnormalities, especially
of the ST segment or T wave, frequently occur in coma-
tose encephalopathic patients [4, 12], but ST/T wave
changes in non-encephalopathic subjects have been
reported [4, 9, 12–14]. Sudden unexplained death due to
paracetamol overdose may occur early before acute hep-
atic failure is established, and even in the complete ab-
sence of histological evidence of hepatic necrosis [9, 14].
A direct toxic myocarditis has been postulated from aut-
opsy evidence of myocardial necrosis being present par-
ticularly in the sub endocardium [9, 14, 15]. Cases of
Toxic myocarditis, acute myocardial necrosis following
paracetamol poisoning have been reported [9, 11, 14, 15].
The cause of the ECG abnormalities in encephalopathic
patients is probably multifactorial and at least partly re-
lated to severe metabolic changes. However, these cannot
be implicated in patients with less hepatic damage or in
sudden death early in the course of paracetamol poisoning
[4, 9]. Because of this Armour et al. suggested an ECG to
be taken on admission and checked daily if the overdose is
significant [9] They also further stated that if ST/T wave
abnormalities or a dysrhythmia are present, the treatment
with a standard acetylcysteine infusion should be consid-
ered, probably irrespective of the plasma concentration of
paracetamol or time laps from ingestion [9]. Thum and
Borlak showed the presence of metabolic enzyme(Cyto-
chrome p450s) in the heart and suggested the possibility
of metabolic activation of paracetamol [16]. Also literature
review showed a very minimal amount of research had
been carried out to determine paracetamol cardio toxicity
which seems to have been overlooked.
The above evidence would justify paracetamol cardi-
otoxicity being studied in detail amongst our patients.
We carried out a study on patients presenting to the
Toxicology Unit of the Teaching Hospital Peradeniya. We
selected this unit of the Teaching Hospital Peradeniya as
all acute poisoning patients are admitted here.
Methods
The objective of our study was to assess the demo-
graphic and clinical patterns of paracetamol poisoning
induced cardiotoxicity in the Sri Lankan population. The
study population included all patients with a history of
Paracetamol poisoning presenting to the toxicology unit
of the Teaching Hospital Peradeniya over a period of
one year. All patients who were clinically diagnosed to
have paracetamol poisoning after detailed history at the
time of presentation were included in this study. Those
patients with multiple drug poisoning and those who re-
fused to participate were excluded from the study.
Ethical clearance was obtained from the Ethical Review
Committee of the Faculty of Medicine, University of
Peradeniya, and informed written consent was obtained
from all subjects prior to data collection.
All patients presenting with paracetamol poisoning to
the Toxicology Unit of the Teaching Hospital Peradeniya
were assessed by detailed history and examination by in-
vestigators recruited to the study. The patients who were




Toxic myocarditis Reference 9,14,15,29,43
Acute myocardial necrosis Reference 9,11,15,16,43
Subendocardial necrosis Reference 9,14,15
Subendocardial haemorrhage Reference 8







ST/T wave inversions Reference 9,15,17,29,42
Flatten T waves Reference 14,17,43
ST elevation Reference 9,15,29,43
Sinus tachycardia Reference 9,15
Ventricular tachycardia Reference 9,15
Multifocal ventricular ectopics Reference 19
Cardiac asystole Reference 15
Dilated left ventricle Reference 9,15,43
Elevated Troponin Reference 15,29
Acute severe left ventricular failure Reference 29,32
Congestive heart failure Reference 32
Cardiomyopathy Reference 15,26
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confirmed to have a paracetamol poisoning were se-
lected for the study. The toxic dose of paracetamol for
adults is considered to be either a single dose of 7.5–
10 g, which is equivalent to 20 tablets of 500 mg each,
or repeated sub-therapeutic doses exceeding 100 mg/kg/
day. As for healthy children aged between 1 and 6 years
the toxic dose is considered to be between 150 and
200 mg/kg. This toxic dose is defined by the occurrence
of hepatotoxicity which is the main toxic effect of para-
cetamol poisoning, and the cardiotoxic dose has not yet
been determined. All the subjects of this study were
above the age of 15, therefore all subjects who had con-
sumed more than 20 paracetamol tablets were consid-
ered to have paracetamol poisoning.
All the study subjects underwent routine hematological
and biochemical investigations on admission, followed by
4 h blood paracetamol level. In case of unknown time of
ingestion random blood paracetamol level was measured.
Blood paracetamol concentration level against the time
since ingestion was plotted on the Rumak-Mathew nor-
mogram (Fig. 1) to assess paracetamol toxicity.
Liver functions and renal functions were assessed daily
over the next few days. Daily 12 leads ECG was taken,
and was interpreted by a Consultant Physician special-
ized in Cardiology. Serum Troponin I level was mea-
sured at 4 h after ingestion of paracetamol in patients
who were found to have detectable serum paracetamol
levels. In addition basic demographic data was also ob-
tained. Data was collected using a comprehensive data
collection sheet and was analyzed using the SPSS (Statis-
tical package for social sciences) 20.0 software.
Results
Basic socio-demographic data
Studied sample included 68 patients who are ingested 20
or more Paracetamol tablets, with a mean age of 21.38 +/-
5.11 (range 15–36). This included 26(38.2 %) male
patients and 42(61.8 %) females (Table 2) and reason for
Paracetamol ingestion is given in Table 3. Clinical findings
on admission were recorded and is shown in Table 4.
Out of 68 patients, 58(85.3 %) were Sinhalese, 9(13.2 %)
were Muslims and 1(1.5 %) patient was Christian;
16(23.5 %) patients were regular smokers and 18(26.5 %)
were regular alcohol users.
Among the Studied population, 44(64.7 %) only com-
pleted their primary education (Ordinary level), 21(30.9 %)
educated up to Advanced level and only 3(4.4 %) completed
tertiary education.
Out of 68, 47(69.12 %) answered the source of para-
cetamol as Home and 21(30.88 %) patients were taken
Paracetamol over the counter.
All the patients had ingested paracetamol tablets and
the mean number of paracetamol tablets was 37+/- 18.36
(Range20–96) (19 g); 2(2.9 %) of them ingested alcohol
Fig. 1 Paracetamol overdose treatment nomogram
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with paracetamol and 3(4.4 %) ingested cholrophenira-
mine with paracetamol.
Of the 68 subject, 27 (39.70 %) had detectable paracta-
mol levels in serum, and 21 (30.88 %) had Alanine
Transaminase levels (ALT) ≥ 1000 IU/L.
Out of studied sample (68), 9 (13.2 %) had a past his-
tory of Depression, 11(16.2 %) had a chronic illness, and
only 10(14.7 %) had a history of previous suicidal at-
tempts. Eight(11.8 %) had family history of suicide and
6(9 %) had family history of depression.
ECG and Echocardiography were done in all patients.
Approximately, 20.59 % had bradycardia while 2.94 % had
tachycardia. Majority(76.47 %) had normal heart rate.
Fourteen patients(20.59 %) had first degree heart block.
The duration of QRS was normal in all the patients. Small
Q waves were detected in 13.24 % patients and they were
not pathological. ST segment depression was observed in
2.94 % patients and was less than 1 mm and non signifi-
cant.10.29 % patients had T wave inversions in inferior
leads and were considered normal (Table 5). Standard
treatment was given to all patients on admission and dur-
ing the stay in the hospital (Table 6).
Echocardiogram was done on all the patients and did
not reveal any significant abnormality. All of them had
normal ejection fraction and there were no any regional
wall motion abnormalities. There were no hypokinetic
or akinetic segments.
Cardiac Biomarker Troponin I was done only in patients
who had detectable serum paracetamol levels (27 Patients).
Surprisingly Troponin I was negative in all of them.
The average time taken for hospital admission follow-
ing paracetamol ingestion was 3.25 ± 2.27 h.
Discussion
Paracetamol is the most commonly encountered drug
leading to toxicity due to overdose and can lead to severe
complications and even result in death. The commonest
organ system involved in toxicity of paracetamol is the
liver.(H,I) A few previous studies have reported cases of
paracetamol toxicity affecting organs other than the liver,
including the heart, which was assessed in detail by this
study [10, 15, 17–19].
Currently there are a few hypothesized mechanisms
for the occurrence of the previous reported cases of car-
diotoxicity due to paracetamol overdose, which could ei-
ther be a direct or indirect effect. A few studies have
shown the Acetaminophen moiety to have a direct toxic
effect on the heart [9, 14, 20–23]. One hypothesis for
the direct toxic effect on the heart suggests that myocar-
dial injury occurs due to a similar mechanism which
causes hepatic damage, with paracetamol partly con-
verted to a toxic metabolite, N-acetyl-p-benzoquinoni-
mine, which is normally inactivated by reduction with
glutathione and acts as a direct toxin on the myocar-
dium [9]. Paracetamol has shown to bind covalently to
proteins in both the liver and cardiac tissue which re-
sults in the alteration of protein structure and function,
potentially precipitating cytokine release and tissue in-
jury [22, 23]. Another hypothesis is one resulting in is-
chemia due to paracetamol, which can be due to the
depletion of sulfydryl groups. Acetaminophen can de-
plete sulfydryl groups, which interferes with nitric oxide
production, which results in coronary ischaemia [9, 20].
This sulfydryl deficit also may interfere with endothe-
lium derived vascular relaxing factor, which leads to
functional coronary ischemia [9, 20].
The most commonly postulated hypothesis for the
mechanism for cardiotoxicty in paracetamol poisoning is
metabolic derangements such as hyperkalemia, meta-
bolic acidosis and increase in serum fatty acid levels,
resulting by hepatic failure, which could lead to arryth-
mias [9, 12]. Previously reported cases of paracetamol
poisoning with cardiac tissue damage has almost always
been associated with hepatotoxicity. Lesna et al. stated
that there have been no cases of cardiac arrest so far in
the absence of hepatotoxicity, which further justifies the
hypothesis which states that cardiac tissue damage in
paracetamol poisoning occurs following metabolic de-
rangements due to hepatotoxicity [18, 24–27]. Similarly,
in this study 30.88 % had ALT ≥ 1000 IU/L indicating
hepatic tissue injury, but all had negative Troponin I,
Table 2 Age and sex Distribution
Age Group Number Total = 68 Sex
Male(n 26) Female(n 42)
<18 22(32.4 %) 8 14
18-24 31(45.6 %) 11 20
>24 15(22.0 %) 7 8
Table 3 Reason for Paracetamol ingestion
Reason for Paracetamol ingestion Number of patients Percentages (%)
Impulsive action 24 35.3
Deliberate self-harm 14 20.6
Suicidal 30 44.1
Table 4 Clinical data on admission
Clinical findings Number of patients Percentages %
Nausea 55 80.9
Vomiting 48 70.6
Chest Pain 20 29.4
RUQ pain 15 22.1
Jaundice 2 2.9
Confusion 1 1.5
Easy Bleeding 0 0
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Table 5 Electrocardiogram findings of the sample
Heart Rate PR interval(Sec) QRS duration(Sec) Q wave ST depresion T inversion
<60 60-100 >100 <0.12 0.12-0.20 >0.2 <0.12 >0.12 Present Absent Present Absent Present Absent















echocardiogram and ECG, indicating the absence of car-
diac tissue injury in any of the subjects. A case of myo-
cardial damage following acute paracetamol poisoning
by Ohtani et al. reported heart failure to occur 2 weeks
following hepatic injury, and had return of hepatic func-
tion tests to normal and had no elevated levels of serum
paracetamol by that time, which shows that though
there may be no features of cardiac tissue injury or im-
pairment at the time there is hepatic damage, but car-
diac toxicity could occur at a later stage even in the
absence of features of hepatic tissue injury at that stage
[28–32]. Mi Jin et al. in their experiment have demon-
strated that paracetamol induced cytotoxicity and altered
gene expression in cultures cardiomyocytes of H9C2
cells [23]. This study was plan to identify the alterations
in gene expression in cultured cardiomyocytes;H9C2
cells, which are rat cardiomyocytes, were treated with
paracetamol, to evaluate the possible toxic mechanism
in the heart. During this study authors have demon-
strated some of the DNA damage and upregulation of
genes including those associated with oxidative stress,
DNA damage and apoptosis [23]. During this study to
examine toxic effects of paracetamol,H9C2 rat cardio-
myocytes were incubated with different concentratins of
paracetamol and viability was determined at different
time intervals and showed H9C2 cells viability was de-
creased by treatment with paracetamol in a time- and
dose-dependant manner [16]. Another laboratory study
done by Inoue et al. to study cardiotoxicity and hepato-
toxicity of different compounds using neonatal rat heart
cells and rat hepatocytes confirmed that paracetamol
was cardiotoxic in significant overdose [33].
Previous studies have shown that cardiotoxicity follow-
ing paracetamol poisoning may be either immediate or
delayed [20, 21], similar to the case reported by Ohtani
et al. which showed a delay in onset of cardiac involve-
ment [28]. The average time taken for hospital admis-
sion following paracetamol ingestion in this study was
3.25 ± 2.27 h. Probably if these patients were followed up
weeks later, some of them may have developed cardiac
toxicity and showed cardiac tissue damage by elevated
troponin I, or positive echocardiogram or ECG changes.
Since the cardiotoxicity due to paracetamol poisoning is
believed to be either immediate or delayed, it is of
paramount importance to administer N-acetylcysteine
(NAC) as early as possible because it may be beneficial in
reducing the functional coronary ischaemia as well as the
direct toxic effects, irrespective of the time of ingestion
[34–40]. Since a majority of 81 % of subjects were treated
with NAC, and since the time taken for hospital admission
following paracetamol ingestion was short, effective treat-
ment with NAC would’ve been protective against the devel-
opment of cardiotoxicity in this sample. Gastric aspiration
or lavage should be carried out, or emesis induced within
4 h of ingestion of 100 mg/kg of paracetamol to reduce
absorption, and this has been carried out in 39 % of
patients. Activated charcoal and cholestyramine reduce
absorption of paracetamol if given within 1 h of ingestion
[24–26]. 42.1 % of the patients underwent treatment with
charcoal, but since it was done after 1 h of ingestion, the
protective effect from this measure would have been min-
imal or absent. However, other effective measures for the
treatment of paracetamol poisoning may be the reason for
cardiotoxicity not to develop in these patients.
In contrast to the believed toxic potential of paraceta-
mol on the heart, literature has also demonstrated para-
cetamol to have a cardioprotective potential in ischaemia
reperfusion syndrome. At concentrations of 45–50 mg/ml,
well below the clinically toxic dose of 300 mg/ml, para-
cetamol can reduce tissue injury by preventing the open-
ing of the mitochondrial permeability transition pore and
reducing apoptosis [27, 28]. This dose dependent cardio-
protective effect has a different mechanism from that of
the cardiotoxic effect [41, 42]. However, the mean amount
of paracetamol ingested by this study sample was 19 g, ac-
counting to about 315 mg/kg, indicating that this cardio-
protective effect of paracetamol is quite unlikely in this
sample according to the facts stated in literature.
In patients with severe paracetamol poisoning, the ECG
often reveals minor nonspecific ST changes and T wave
flattening with U waves during the first 48 h, which is likely
to be related to hyperkalaemia, but not due to direct cardio-
toxicity [29]. Nonspecific ECG changes and elevated serum
creatine kinase has been reported without clinical evidence
of toxic myocarditis [30, 31]. A post mortem analysis of 20
fatal cases of paracetamol poisoning showed that there was
no evidence of cardiomyopathy. Some degree of focal nec-
rotizing myopathy has been found to occur in patients with
fatal massive hepatic necrosis of diverse etiology [32, 33].
Serious cardiovascular complications in paracetamol over-
dose are not heard of in the absence of hepatic failure, and
cardiac abnormalities reported in certain fatal cases are due
to the profound metabolic disturbances of acute liver failure
rather than paracetamol itself.
In contrast, there have been a few very rare cases of
paracetamol overdose reported with abnormal ECG pat-
terns in the absence of hepatotoxicity, metabolic de-
rangement or encephalopathy [32, 43]. A similar case of
a 29 year old man with significant paracetamol overdose
Table 6 Treatment modalities
Modality Number Percentages
Gastric Lavage 23 39
Activated Charcoal 29 42.1
NAC 47 81
Methionine 11 18.6
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was found to have an abnormal ECG in the absence of
hepatic encephalopathy [9].
Approximately 35.3 % ingested paracetamol overdose
by impulsive action, 20.6 % for deliberate self-harm, and
44.1 % for suicide. 11.8 % had a family history of suicide
and 9 % had a family history of depression. Considering
these facts, there is also a possibility that a certain num-
ber of patients may have mentioned an exaggerated
number of paracetamol tablets ingested, and some may
also not be very sure of the time and details of ingestion
of the overdose. There is also the possibility that para-
cetamol tablets may have a more diluted concentration
of the drug in its composition with a hindrance of qual-
ity, resulting in a lower level of serum paracetamol than
expected compared to the number of tablets ingested.
Conclusion
Cardiotoxicity is not a common presentation in para-
cetamol poisoning. It further justifies certain previous
studies which state that if at all any cardiac tissue dam-
age only occurs due to metabolic derangements follow-
ing hepatotoxicity.
Abbreviations
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